Timber Pharmaceuticals, Inc. (TMBR) has a market capitalization of $1.18M and trades at $0.34. The 52-week range is 0.32-3.39.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-9.19, annual revenue of $83.18K.
The stock has a beta of -0.65, operates in the Healthcare sector.
